Takeda: strategic alliance with Canada’s enGene on gene therapy for diseases of the digestive system

enGene has developed „Gene Plii“, an oral, non-viral gene therapy based on chitosan encapsulation which allows a highly flexible nucleotide (DNA and RNAi) delivery to mucosal tissues targeting chronic diseases via the induction or suppression of protein expression levels.

Takeda news release, January 12, 2016

Most popular posts: